These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15470656)

  • 21. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts.
    Li KY; Zhang YJ
    Acta Cardiol; 2015 Feb; 70(1):67-72. PubMed ID: 26137805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
    Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
    Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of angiotensin II receptor antagonism on matrix metalloproteinases and fibronectin in rats with experimental myocardial infarction].
    Zhang X; Yang YJ; Zhu WL; Huang Y; Zhu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1029-34. PubMed ID: 17288771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
    Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
    Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.
    Fujiwara Y; Shiraya S; Miyake T; Yamakawa S; Aoki M; Makino H; Nishimura M; Morishita R
    Int J Mol Med; 2008 Dec; 22(6):703-8. PubMed ID: 19020766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
    Xu J; Carretero OA; Shesely EG; Rhaleb NE; Yang JJ; Bader M; Yang XP
    Exp Physiol; 2009 Mar; 94(3):322-9. PubMed ID: 19060116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit.
    Uemura K; Li M; Tsutsumi T; Yamazaki T; Kawada T; Kamiya A; Inagaki M; Sunagawa K; Sugimachi M
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2254-61. PubMed ID: 17693545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
    Koid SS; Ziogas J; Campbell DJ
    Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
    Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
    J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
    Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valsartan: a review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction.
    Croom KF; Keating GM
    Am J Cardiovasc Drugs; 2004; 4(6):395-404. PubMed ID: 15554725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.
    Tian H; Huang ML; Liu KY; Jia ZB; Sun L; Jiang SL; Liu W; McDonald Kinkaid HY; Wu J; Li RK
    Cell Transplant; 2012; 21(5):1039-53. PubMed ID: 21944319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.
    Nilsson L; Hallén J; Atar D; Jonasson L; Swahn E
    Heart; 2012 Jan; 98(1):31-6. PubMed ID: 21727201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction.
    Jiao KL; Li YG; Zhang PP; Chen RH; Yu Y
    J Cell Mol Med; 2012 Jun; 16(6):1342-51. PubMed ID: 22128836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
    Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.